RCM

RA Capital Management Portfolio holdings

AUM $9.44B
1-Year Est. Return 157.3%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+157.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.44B
AUM Growth
-$323M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1 +$216M
2 +$114M
3 +$106M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$75.5M
5
NUVL icon
Nuvalent
NUVL
+$66.7M

Top Sells

1 +$743M
2 +$623M
3 +$82.6M
4
BLTE
Belite Bio
BLTE
+$69.2M
5
IVVD icon
Invivyd
IVVD
+$42.3M

Sector Composition

1 Healthcare 99.71%
2 Financials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$13.8B
$2.35B 24.92%
10,281,496
PCVX icon
2
Vaxcyte
PCVX
$7.42B
$667M 7.07%
11,474,599
+750,000
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$6.05B
$580M 6.14%
6,666,837
TYRA icon
4
Tyra Biosciences
TYRA
$1.99B
$467M 4.95%
12,198,625
SION
5
Sionna Therapeutics
SION
$1.93B
$397M 4.21%
9,905,045
EWTX icon
6
Edgewise Therapeutics
EWTX
$3.68B
$328M 3.48%
10,428,437
NAMS icon
7
NewAmsterdam Pharma
NAMS
$3.94B
$306M 3.24%
9,550,191
NUVL icon
8
Nuvalent
NUVL
$8.72B
$260M 2.75%
2,534,145
+654,088
DNTH icon
9
Dianthus Therapeutics
DNTH
$5.08B
$219M 2.32%
2,611,733
+1,000,000
MLYS icon
10
Mineralys Therapeutics
MLYS
$2.6B
$208M 2.21%
7,692,750
+369,000
SGP
11
SpyGlass Pharma
SGP
$644M
$208M 2.2%
+8,021,117
WVE icon
12
Wave Life Sciences
WVE
$1.27B
$196M 2.07%
26,975,505
+8,772,496
SEPN
13
Septerna Inc
SEPN
$1.36B
$168M 1.78%
6,995,858
IRON icon
14
Disc Medicine
IRON
$2.66B
$157M 1.66%
2,450,221
+474,089
JANX icon
15
Janux Therapeutics
JANX
$890M
$156M 1.65%
11,189,693
BCRX icon
16
BioCryst Pharmaceuticals
BCRX
$2.26B
$151M 1.6%
15,827,186
BCAX
17
Bicara Therapeutics
BCAX
$1.43B
$144M 1.53%
7,255,993
+300,000
PRAX icon
18
Praxis Precision Medicines
PRAX
$9.76B
$120M 1.28%
373,787
GHRS icon
19
GH Research
GHRS
$1.65B
$108M 1.14%
7,676,697
ZLAB icon
20
Zai Lab
ZLAB
$1.99B
$107M 1.14%
+5,707,262
TSHA icon
21
Taysha Gene Therapies
TSHA
$1.69B
$105M 1.12%
23,555,648
VOR icon
22
Vor Biopharma
VOR
$811M
$96.4M 1.02%
5,404,998
GERN icon
23
Geron
GERN
$802M
$95M 1.01%
63,771,366
SPRY icon
24
ARS Pharmaceuticals
SPRY
$901M
$87.2M 0.92%
10,860,977
SRPT icon
25
Sarepta Therapeutics
SRPT
$1.89B
$84.9M 0.9%
+3,902,596